These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3071347
1. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man. Linch DC, Devereux S, Addison IE. Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347 [Abstract] [Full Text] [Related]
4. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. Rifkin RM, Hersh EM, Salmon SE. Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327 [Abstract] [Full Text] [Related]
9. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor. Steward WP, Scarffe JH, Bonnem E, Crowther D. Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743 [Abstract] [Full Text] [Related]
10. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure. Shadduck RK, Rosenfeld CS, Sulecki M, Phillips N, Przepiorka D, Earle M, Stoller R, Jacobs S. Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742 [Abstract] [Full Text] [Related]
12. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Lieschke GJ, Maher D, Cebon J, O'Connor M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D. Ann Intern Med; 1989 Mar 01; 110(5):357-64. PubMed ID: 2644886 [Abstract] [Full Text] [Related]
13. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Monroy RL, Skelly RR, Taylor P, Dubois A, Donahue RE, MacVittie TJ. Exp Hematol; 1988 Jun 01; 16(5):344-8. PubMed ID: 3286278 [Abstract] [Full Text] [Related]
14. Clinical role of granulocyte-macrophage colony-stimulating factor. Mitsuyasu RT, Golde DW. Hematol Oncol Clin North Am; 1989 Sep 01; 3(3):411-25. PubMed ID: 2698875 [Abstract] [Full Text] [Related]
15. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes. Hoelzer D, Ganser A, Greher J, Völkers B, Walther F. Behring Inst Mitt; 1988 Aug 01; (83):134-8. PubMed ID: 3071328 [Abstract] [Full Text] [Related]
17. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia]. Shi YK, Sun Y, Su M. Zhonghua Zhong Liu Za Zhi; 1994 Sep 01; 16(5):356-9. PubMed ID: 7895587 [Abstract] [Full Text] [Related]